4/9
08:10 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $12.00 price target on the stock.
4/9
07:46 am
crmd
Rating for CRMD
Medium
Report
Rating for CRMD
4/9
07:46 am
crmd
Rating for CRMD
Medium
Report
Rating for CRMD
3/26
11:15 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
3/26
11:15 am
crmd
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
Low
Report
CorMedix Inc. (NASDAQ: CRMD) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $12.00 price target on the stock.
3/26
11:11 am
crmd
Rating for CRMD
Low
Report
Rating for CRMD
3/26
11:11 am
crmd
Rating for CRMD
Low
Report
Rating for CRMD
3/26
07:03 am
crmd
Rating for CRMD
Medium
Report
Rating for CRMD
3/26
07:03 am
crmd
Rating for CRMD
Medium
Report
Rating for CRMD
3/7
08:51 am
crmd
Rating for CRMD
Medium
Report
Rating for CRMD
3/7
07:25 am
crmd
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $18.00 price target on the stock.
Medium
Report
CorMedix Inc. (NASDAQ: CRMD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $18.00 price target on the stock.
3/7
06:24 am
crmd
CorMedix initiated with an Outperform at Leerink
High
Report
CorMedix initiated with an Outperform at Leerink